Other Income/Expenses (Net)

-$412.00M

TTM · Period ending: Jun 30, 2026 · USD

EW Other Income/Expenses (Net)

Latest reported-$412.00Mperiod endingJun 30, 2026

EW TTM Other Income/Expenses (Net) (-$350.40M → -$412.00M)

TTM Other Income/Expenses (Net)

High-resolution chart · PNG

EW other income/expenses (net) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Edwards Lifesciences Other Income/Expenses (Net) — Trailing twelve months (TTM) (USD)
Period ending	Other Income/Expenses (Net) (USD)
Jun 30, 2026	-412,000,001
Mar 31, 2026	-443,000,000
Dec 31, 2025	-348,200,000
Sep 30, 2025	9,200,000
Jun 30, 2025	138,100,000
Mar 31, 2025	190,700,000
Dec 31, 2024	167,300,000
Sep 30, 2024	100,300,000
Jun 30, 2024	89,200,000
Mar 31, 2024	-28,200,000
Dec 31, 2023	-48,100,000
Sep 30, 2023	-8,800,000
Jun 30, 2023	-69,800,000
Mar 31, 2023	62,000,000
Dec 31, 2022	66,600,000
Sep 30, 2022	31,300,000
Jun 30, 2022	34,900,000
Mar 31, 2022	93,500,000
Dec 31, 2021	91,600,000
Sep 30, 2021	70,900,000
Jun 30, 2021	100,500,000
Mar 31, 2021	-383,800,000
Dec 31, 2020	-379,300,000
Sep 30, 2020	-394,700,000
Jun 30, 2020	-392,800,000
Mar 31, 2020	-2,800,000
Dec 31, 2019	-29,400,000
Sep 30, 2019	-299,700,000
Jun 30, 2019	-321,600,000
Mar 31, 2019	-353,400,000
Dec 31, 2018	-330,900,000
Sep 30, 2018	43,500,000
Jun 30, 2018	44,000,000
Mar 31, 2018	26,000,000
Dec 31, 2017	13,100,000
Sep 30, 2017	-77,900,000
Jun 30, 2017	-85,300,000
Mar 31, 2017	-48,100,000
Dec 31, 2016	-53,300,000
Sep 30, 2016	-52,500,000
Jun 30, 2016	-44,000,000
Mar 31, 2016	-36,600,000
Dec 31, 2015	-20,300,000
Sep 30, 2015	-20,000,000
Jun 30, 2015	-23,800,000
Mar 31, 2015	674,700,000
Dec 31, 2014	661,400,000
Sep 30, 2014	648,900,000
Jun 30, 2014	652,100,000
Mar 31, 2014	-47,800,000
Dec 31, 2013	45,500,000
Sep 30, 2013	55,700,000
Jun 30, 2013	60,200,000
Mar 31, 2013	60,300,000
Dec 31, 2012	-17,300,000
Sep 30, 2012	-25,500,000
Jun 30, 2012	-26,600,000
Mar 31, 2012	-23,200,000
Dec 31, 2011	-16,500,000
Sep 30, 2011	-9,100,000
Jun 30, 2011	-8,000,000
Mar 31, 2011	-12,700,000
Dec 31, 2010	-16,100,000
Sep 30, 2010	-7,600,000
Jun 30, 2010	31,400,000
Mar 31, 2010	38,900,000
Dec 31, 2009	66,400,000
Sep 30, 2009	47,500,000
Jun 30, 2009	9,000,000
Mar 31, 2009	8,100,000
Dec 31, 2008	-33,900,000
Sep 30, 2008	-38,800,000
Jun 30, 2008	-35,900,000
Mar 31, 2008	-35,600,000
Dec 31, 2007	-23,900,000
Sep 30, 2007	-17,500,000
Jun 30, 2007	-23,200,000
Mar 31, 2007	-23,100,000
Dec 31, 2006	-23,100,000
Sep 30, 2006	-7,400,000
Jun 30, 2006	-28,700,000
Mar 31, 2006	-59,200,000
Dec 31, 2005	-59,200,000
Sep 30, 2005	-61,200,000
Jun 30, 2005	-52,200,000
Mar 31, 2005	-27,900,000
Dec 31, 2004	-108,900,000
Sep 30, 2004	-115,300,000
Jun 30, 2004	-116,700,000
Mar 31, 2004	-112,400,000
Dec 31, 2003	-42,300,000
Sep 30, 2003	-31,900,000
Jun 30, 2003	-19,000,000
Mar 31, 2003	-4,200,000
Dec 31, 2002	3,900,000
Sep 30, 2002	1,400,000
Jun 30, 2002	2,300,000
Mar 31, 2002	-28,800,000
Dec 31, 2001	-33,000,000
Sep 30, 2001	-41,100,000